Publications by authors named "Ana Celis"
Background: Dupilumab is a treatment approved for uncontrolled moderate-to-severe atopic dermatitis (AD). Tropical and developing countries such as Colombia have characteristics that may impact the natural history of AD and access to medical treatments. In that sense, we aimed to describe the effectiveness and safety of dupilumab in adults with moderate to severe AD in a Colombian multicenter cohort.
View Article and Find Full Text PDFPrevalence of Inducible Urticaria in Patients with Chronic Spontaneous Urticaria: Associated Risk Factors.
J Allergy Clin Immunol Pract
November 2017
Article Synopsis
- The study investigates the frequency of inducible urticaria (IU) in patients with chronic spontaneous urticaria (CSU) and identifies factors influencing this prevalence.
- Among 245 CSU patients, 75.9% reported physical triggers, but only 36.3% tested positive for IU, with symptomatic dermographism being the most common.
- Results suggest that geographical differences affect IU prevalence, and factors like atopy and self-reactivity significantly contribute to CSU development.